NASDAQ:TRDA | Cash Flow Statement | Entrada Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$42.76M
2026-03-31-$39.72M-$41.7M$44,000.00$26.99M$100,000.00
2025-12-31-$39.16M-$32.2M-$207,000.00$29.12M$192,000.00
2025-09-30-$44.13M
2025-06-30-$43.1M
2025-03-31-$17.35M-$38.51M$1.14M$4.78M$350,000.00
2024-12-31$1.13M-$31.61M$635,000.00$53.37M$1.4M
2024-09-30-$14.03M
2024-06-30$55.03M
2024-03-31$23.5M-$25.52M$838,000.00$26.15M$206,000.00
2023-12-31-$9.54M-$4.01M$976,000.00$19.04M$690,000.00
2023-09-30$35.46M
2023-06-30-$25.93M
2023-03-31-$6.67M$203.4M$1.67M-$40.44M$19.54M
2022-12-31-$24.63M-$27.3M$708,000.00$18.79M$358,000.00
2022-09-30-$25.14M
2022-06-30-$23.18M
2022-03-31-$21.67M-$20.99M$594,000.00-$181.53M$50,000.00
2021-12-31-$18.45M-$20.54M$1.32M-$1.32M$190.76M
2021-09-30-$14.43M
2021-06-30-$9.9M
2021-03-31-$8.38M-$8.34M$908,000.00-$908,000.00$116.39M
2020-12-31-$8.67M-$6.62M$1.44M-$1.45M$149,000.00
2020-09-30-$6.99M
2020-06-30-$6.17M
2020-03-31-$4.69M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$143.75M-$128.51M$1.04M$116.81M$887,000.00
2024-12-31$65.63M-$41.56M$3.16M-$27.8M$102.96M
2023-12-31-$6.69M$139.8M$5.61M-$138.4M$21.04M
2022-12-31-$94.62M-$93.79M$2.89M-$148.65M$479,000.00
2021-12-31-$51.16M-$50.86M$4.58M-$4.58M$307.46M
2020-12-31-$26.52M-$25.57M$2.32M-$2.32M$50.09M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.